Newstral
C. Michael Gibson
- Health behemoth CSL sheds $7b in value after heart drug fails trialSydney Morning Herald
- Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment SuccessForbes
- MPortola Pharma stock skyrockets after FDA approves anticoagulant for high-risk patientsmarketwatch.com
- Updated: Cholesterol drug shows promise to help reverse heart diseaseabqjournal.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.